Abstract:Abstract In general, ‘poorly’ differentiated tumours have a worse prognosis when compared to more ‘well’ differentiated ones. Therefore, the use of a biological agent that could promote differentiation might have a therapeutic advantage. CCAAT enhancer binding protein alpha (C/EBPα) is a transcription factor known to be involved in the regulation of cell differentiation in a number of tissue types. Loss of C/EBPα expression, for example, causes abnormal levels of biliary transcription factors, impaired hepatocyte maturation and liver fibrosis. In contrast C/EBPα overexpression inhibits the development of hepatocellular carcinoma, restores myeloid differentiation and prevents hyperproliferation of hematopoietic cells in acute myeloid leukemia. In this study, we tested the effect of stimulation of C/EBPα expression by a specific small activating RNA (saRNA) on a panel of cell lines representing both well-differentiated and poorly-differentiated cancer cell types. The C/EBPα-saRNA inhibited proliferation of poorly differentiated small cell lung cancer and pancreatic cancer cell lines compared to treatment with scrambled double-stranded RNA controls. However C/EBPα-saRNA was not as effective in suppressing proliferation in well-differentiated insulinoma and breast cancer (MCF7) cell lines. Comparison of endogenous levels of C/EBPα, using qPCR and Western blots, showed that undifferentiated tumour cell lines expressed lower levels of C/EBPα when compared to the well-differentiated tumor types. Gene expression analysis in tumours from xenografts and cirrhotic DEN treated HCC rats, demonstrated that saRNA mediated stimulation of C/EBPα expression, could suppress the steady-state transcript levels for KLF4, OCT3, SOX2, C-Myc and C-Kit. The inhibited expression of these transcription factors correlated with greater expression of differentiation markers and reduced epithelial mesenchymal transition by the C/EBPα saRNA treated cells. Our results suggest that saRNA mediated stimulation of C/EBPα, could be of potential therapeutic value, especially in poorly differentiated cancers. Furthermore, intracellular expression levels of C/EBPα could be an important prognostic factor for predicting the therapeutic response in poor or un-differentiated tumors. Citation Information: Mol Cancer Ther 2013;12(11 Suppl):B225. Citation Format: K W. Huang, Vikash Reebye, Paul J. Mintz, Pal Saetrom, Piotr Swiderski, L Peng, C Liu, X X. Liu, Steen Lindkaer Jensen, Dimitris Zacharoulis, Nikos Kostomitsopoulos, Noriyaki Kasahara, Joanna Nicholls, Long R. Jiao, Madhava Pai, Duncan Spalding, Farzin Farzaneh, Malkhaz Mizandari, Tina Chikovani, Mohammed Emara, Abdelali Haoudi, Don Tomalia, John J. Rossi, Nagy A. Habib. Short activating RNA (saRNA) targeting C/EBPA significantly inhibits cell proliferation of undifferentiated cancer cells. [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; 2013 Oct 19-23; Boston, MA. Philadelphia (PA): AACR; Mol Cancer Ther 2013;12(11 Suppl):Abstract nr B225.

Tumor Suppression by Rna from C/Ebp Beta 3 ' Utr Through the Inhibition of Protein Kinase C Epsilon Activity

Molecular Mechanism of Tumor Suppression Activity of C/Ebp Beta Mrna 3 ' Utr: Simultaneous Deletion of 3 Short Sequences in the 3 ' Utr Reduces Its Tumor Suppression Activity

Sequences Near Both Termini of the C/EBPbeta Mrna 3' Untranslated Region Are Important for Its Tumor Suppression Activity.

CSTF2-Induced Shortening of the RAC1 3 ' UTR Promotes the Pathogenesis of Urothelial Carcinoma of the Bladder

Cancer cell growth suppression by a 62nt AU-rich RNA from C/EBPβ 3'UTR through competitive binding with HuR.

The Ccr2 3 ' Utr Functions As A Competing Endogenous Rna to Inhibit Breast Cancer Metastasis

RBPJ Inhibits the Movability of Endometrial Carcinoma Cells by Mir-155/Nf-κb/ros Pathway

3'UTR-directed, kinase proximal mRNA decay inhibits C/EBPβ phosphorylation/activation to suppress senescence in tumor cells

Transcriptomic Analyses of Rna-Binding Proteins Reveal Eif3c Promotes Cell Proliferation in Hepatocellular Carcinoma

The Tumor Suppressive Role of eIF3f and Its Function in Translation Inhibition and rRNA Degradation

Suppression of Migration and Invasion of PC3 Prostate Cancer Cell Line Via Activating E-Cadherin Expression by Small Activating RNA

Protein kinase Cι promotes UBF1-ECT2 binding on ribosomal DNA to drive rRNA synthesis and transformed growth of non-small-cell lung cancer cells

Short Activating Rna (sarna) Targeting C/Ebpa Significantly Inhibits Cell Proliferation of Undifferentiated Cancer Cells.

3′ UTR shortening represses tumor-suppressor genes in trans by disrupting ceRNA crosstalk

RNA binding protein RBMS3 is a common EMT effector that modulates triple-negative breast cancer progression via stabilizing PRRX1 mRNA

CEP55 3'-UTR promotes epithelial-mesenchymal transition and enhances tumorigenicity of bladder cancer cells by acting as a ceRNA regulating miR-497-5p

Preliminary Validation of ERBB2 Expression Regulated by Mir-548D-3p and Mir-559.

Mechanisms Involved in the Activation of C/EBPα by Small Activating RNA in Hepatocellular Carcinoma.

Rna-Interference-Mediated Cdc42 Silencing Down-Regulates Phosphorylation Of Stat3 And Suppresses Growth In Human Bladder-Cancer Cells

Post-transcriptional Modulation of Protein Phosphatase PPP2CA and Tumor Suppressor PTEN by Endogenous Sirna Cleaved from Hairpin Within PTEN Mrna 3′UTR in Human Liver Cells

The 3′UTR of the Pseudogene CYP4Z2P Promotes Tumor Angiogenesis in Breast Cancer by Acting As a Cerna for CYP4Z1